Elemer Piros Stock Analyst Profile - LUCID CAPITAL MARKETS Research Coverage - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Elemer Piros

    Stock Analyst at LUCID CAPITAL MARKETS

    (3.7)
    # 2325
    Out of 5,504 analysts
    143
    Total ratings
    Success rate
    Average return
    Main Sectors:
    Healthcare
    Top Industries:
    Biotechnology Medical - Care Facilities Drug Manufacturers - Specialty & Generic

    49 Stocks

    Name Action PT Current % Upside Ratings Updated
    BTAI BioXcel Therapeutics
    Reiterates: Buy
    66 66
    		2.54 2498.43% 2 Jul 15, 2025
    FBLG FibroBiologics
    Initiates Coverage On: Buy
    12
    		0.55 2081.82% 1 Dec 12, 2024
    THAR Tharimmune
    Initiates Coverage On: Buy
    17
    		2.92 482.19% 1 Dec 6, 2024
    QNCX Quince Therapeutics
    Initiates Coverage On: Buy
    11
    		1.68 554.76% 1 Oct 29, 2024
    MNPR Monopar Therapeutics
    Initiates Coverage On: Buy
    50
    		99.5 -49.75% 6 Oct 11, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    17
    		1.35 1159.26% 1 Sep 30, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    220
    		4.11 5252.8% 1 Aug 19, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    107 107
    		3.63 2847.66% 1 Aug 8, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    14 14
    		1.54 809.09% 1 Jul 2, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    67 67
    		2.22 2918.02% 1 Jul 2, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    43
    		6.76 536.09% 1 Jun 21, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    18
    		6.04 198.01% 7 Jun 13, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    12 8
    		1.57 377.71% 3 Sep 14, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    15 15
    		5.21 187.91% 8 Aug 9, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    21
    		12.56 67.2% 8 Aug 4, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    38
    		6.42 491.9% 9 Aug 3, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    40
    		0.79 4963.29% 2 Jul 10, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    50
    		4.61 984.6% 5 Jun 30, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    114
    		6.08 1775% 3 Jun 20, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    260 200
    		10.55 1795.73% 6 Jun 20, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    23
    		n/a n/a 2 May 16, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    33
    		13.12 151.52% 3 Mar 2, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    11
    		n/a n/a 2 Feb 14, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Sell
    40
    		23.79 68.14% 7 Apr 14, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Upgrades: Buy
    40
    		n/a n/a 3 Jan 4, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    37
    		1.5 2366.67% 1 Dec 1, 2021
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    38 32
    		7.07 352.62% 2 Jun 30, 2021
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    128 124
    		n/a n/a 7 May 6, 2021
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    10
    		n/a n/a 1 Apr 28, 2021
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Sell
    77
    		22.57 241.16% 2 Dec 23, 2020
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    70
    		n/a n/a 1 Oct 12, 2020
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    240
    		n/a n/a 1 Sep 17, 2020
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    n/a
    		n/a n/a 5 Sep 8, 2020
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    21 24
    		n/a n/a 4 May 28, 2020
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    225 75
    		n/a n/a 2 May 12, 2020
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Neutral
    24 50
    		36.13 38.39% 5 Nov 19, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Assumes: Overweight
    33
    		5.74 474.91% 2 Oct 22, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Overweight
    191 186
    		n/a n/a 4 Aug 8, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Upgrades: Overweight
    n/a
    		n/a n/a 3 Jul 11, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Overweight
    26
    		4.57 468.93% 3 May 6, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    80 115
    		n/a n/a 3 Feb 25, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Overweight
    21
    		n/a n/a 1 Nov 7, 2018
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Overweight
    28
    		183.57 -84.75% 1 Sep 11, 2018
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    14 17
    		n/a n/a 2 Aug 9, 2018
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    70 65
    		n/a n/a 2 Jun 13, 2018
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    525 850
    		5.39 15669.94% 1 Oct 12, 2017
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    204 84
    		n/a n/a 2 Sep 22, 2017
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Overweight
    29
    		n/a n/a 1 Jul 20, 2017
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    35 21
    		11.4 84.21% 2 Jul 12, 2017